At Lantheus Medical Imaging, we are building our future on a foundation of more than a half-century of innovation and leadership in medical imaging. Our efforts to illuminate the future of medical imaging include a promising program to develop a Positron Emission Tomography (PET) perfusion imaging agent, which is now in Phase 1 clinical trials. We also have early-stage programs underway in the areas of heart failure and in imaging vulnerable plaque.

DEFINITY®/LUMINITY®
We currently have Phase 4 clinical trials underway to further define and expand the clinical utility of DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension, and have a continuing interest in pursuing additional indications in echocardiography and radiology.